Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myasthenia Gravis × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13 Polycystic Ovary Syndrome 8 Neoplasms 3 Endometrial Neoplasms 3 Prostatic Neoplasms 2 Obesity 2 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Diabetes Mellitus 2 Colorectal Neoplasms 2 Cognitive Dysfunction 2 Cardiotoxicity 2 Weight Gain 1 Vomiting 1 Venous Thromboembolism 1 Vascular Malformations 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Smoking 1 Skin Toxicity 1

Interventions

Rituximab 6 Pyridostigmine Bromide 5 Prednisone 5 Hizentra 4 telitacicept 3 efgartigimod alfa 3 thymoglobulin 2 Thymectomy 2 Steroids 2 Immunoglobulins, Intravenous 2 Data Collection 2 Cyclophosphamide 2 Blood Specimen Collection 2 Azathioprine 2 zilucoplan 1 tofacitinib 1 tocilizumab 1 sargramostim 1 prednylidene 1 gamma-Globulins 1 fludarabine 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 bu-zhong-yi-qi-tang 1 apraclonidine 1 Walk Test 1 Tacrolimus 1 Tablets 1 Sugars 1 Sugammadex 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03914638 2020-04-06

BETA-MG

University of Aarhus

Phase 2/3 Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡